Quarterly Result14 Aug 2026, 06:44 pm
ANG Lifesciences Declares Un-audited Q1 FY27 Results
AI Summary
ANG Lifesciences India Ltd announced its standalone and consolidated un-audited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on August 14, 2026. A limited review report for the same period was also presented. The company operates in Pharmaceuticals and Printing & Packaging segments. Detailed financial figures for revenue, expenses, and profit/loss for both standalone and consolidated statements were provided, along with segment-wise performance.
Key Highlights
- Board approved standalone and consolidated un-audited Q1 FY27 results.
- Limited Review Report for Q1 FY27 was also approved.
- Results were reviewed by the Audit Committee and approved by the Board.
- Company operates in Pharmaceuticals and Printing & Packaging segments.
Price Impact
More from ANG